• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中脑胆碱能神经末梢完整性与主要运动特征

Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson's disease.

作者信息

Bohnen Nicolaas I, Kanel Prabesh, Koeppe Robert A, Sanchez-Catasus Carlos A, Frey Kirk A, Scott Peter, Constantine Gregory M, Albin Roger L, Müller Martijn L T M

机构信息

Department of Radiology, University of Michigan, Ann Arbor, MI 48105, USA.

Department of Neurology, University of Michigan, Ann Arbor, MI 48105, USA.

出版信息

Brain Commun. 2021 May 22;3(2):fcab109. doi: 10.1093/braincomms/fcab109. eCollection 2021.

DOI:10.1093/braincomms/fcab109
PMID:34704022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8196256/
Abstract

Clinical effects of anti-cholinergic drugs implicate cholinergic systems alterations in the pathophysiology of some cardinal motor impairments in Parkinson's disease. The topography of affected cholinergic systems deficits and motor domain specificity are poorly understood. Parkinson's disease patients ( = 108) underwent clinical and motor assessment and vesicular acetylcholine transporter [F]-fluoroethoxybenzovesamicol PET imaging. Volumes-of-interest-based analyses included detailed thalamic and cerebellar parcellations. Successful PET sampling for most of the small-sized parcellations was available in 88 patients. A data-driven approach, stepwise regression using the forward selection method, was used to identify cholinergic brain regions associating with cardinal domain-specific motor ratings. Regressions with motor domain scores for model-selected regions followed by confounder analysis for effects of age of onset, duration of motor disease and levodopa equivalent dose were performed. Among 7 model-derived regions associating with postural instability and gait difficulties domain scores three retained significance in confounder variable analysis: medial geniculate nucleus (standardized β = -0.34, = -3.78,  = 0.0003), lateral geniculate nucleus (β = -0.32, = -3.4,  = 0.001) and entorhinal cortex (β = -0.23, = -2.6,  = 0.011). A sub-analysis of non-episodic postural instability and gait difficulties scores demonstrated significant effects of the medial geniculate nucleus, entorhinal cortex and globus pallidus pars interna. Among 6 tremor domain model-selected regions two regions retained significance in confounder variable analysis: cerebellar vermis section of lobule VIIIb (β = -0.22, = -2.4,  = 0.021) and the putamen (β = -0.23, = -2.3,  = 0.024). None of the three model-selected variables for the rigidity domain survived confounder analysis. Two out of the four model-selected regions for the distal limb bradykinesia domain survived confounder analysis: globus pallidus pars externa (β = 0.36,  = 3.9,  = 0.0097) and the paracentral lobule (β = 0.26,  = 2.5,  = 0.013). Emphasizing the utility of a systems-network conception of the pathophysiology of Parkinson's disease cardinal motor features, our results are consistent with specific deficits in basal forebrain corticopetal, peduncupontine-laterodorsal tegmental complex, and medial vestibular nucleus cholinergic pathways, against the background of nigrostriatal dopaminergic deficits, contributing significantly to postural instability, gait difficulties, tremor and distal limb bradykinesia cardinal motor features of Parkinson's disease. Our results suggest significant and distinct consequences of degeneration of cholinergic peduncupontine-laterodorsal tegmental complex afferents to both segments of the globus pallidus. Non-specific regional cholinergic nerve terminal associations with rigidity scores likely reflect more complex multifactorial signalling mechanisms with smaller contributions from cholinergic pathways.

摘要

抗胆碱能药物的临床效果表明,胆碱能系统改变在帕金森病某些主要运动障碍的病理生理学中起作用。受影响的胆碱能系统缺陷的拓扑结构和运动领域特异性尚不清楚。108例帕金森病患者接受了临床和运动评估以及囊泡乙酰胆碱转运体[F]-氟乙氧基苯并维司米可PET成像。基于感兴趣区域的分析包括详细的丘脑和小脑分区。88例患者可对大多数小尺寸分区进行成功的PET采样。采用数据驱动方法,即使用向前选择法的逐步回归,来识别与主要领域特异性运动评分相关的胆碱能脑区。对模型选择区域的运动领域评分进行回归分析,然后对发病年龄、运动疾病持续时间和左旋多巴等效剂量的影响进行混杂因素分析。在与姿势不稳和步态困难领域评分相关的7个模型衍生区域中,有3个在混杂变量分析中仍具有显著性:内侧膝状体(标准化β=-0.34,t=-3.78,P=0.0003)、外侧膝状体(β=-0.32,t=-3.4,P=0.001)和内嗅皮质(β=-0.23,t=-2.6,P=0.011)。对非发作性姿势不稳和步态困难评分的亚分析显示,内侧膝状体、内嗅皮质和苍白球内侧部有显著影响。在与震颤领域模型选择的6个区域中,有2个区域在混杂变量分析中仍具有显著性:小叶VIIIb的小脑蚓部(β=-0.22,t=-2.4,P=0.021)和壳核(β=-0.23,t=-2.3,P=0.024)。在混杂因素分析中,刚性领域的3个模型选择变量均未通过。远端肢体运动迟缓领域的4个模型选择区域中有2个在混杂因素分析中通过:苍白球外侧部(β=0.36,t=3.9,P=0.0097)和中央旁小叶(β=0.26,t=2.5,P=0.013)。强调帕金森病主要运动特征病理生理学的系统网络概念的实用性,我们的结果与基底前脑向心性、脚桥被盖外侧被盖复合体和内侧前庭核胆碱能通路的特定缺陷一致,在黑质纹状体多巴胺能缺陷的背景下,对帕金森病的姿势不稳、步态困难、震颤和远端肢体运动迟缓主要运动特征有显著贡献。我们的结果表明,胆碱能脚桥被盖外侧被盖复合体传入苍白球两部分的变性有显著且不同的后果。非特异性区域胆碱能神经末梢与刚性评分的关联可能反映了更复杂的多因素信号机制,胆碱能通路的贡献较小。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c6a/8196256/52182e39d403/fcab109f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c6a/8196256/2027c0756c85/fcab109f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c6a/8196256/718b7a02f956/fcab109f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c6a/8196256/4877a6b17dfe/fcab109f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c6a/8196256/d644af42a08a/fcab109f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c6a/8196256/5e1042d42d09/fcab109f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c6a/8196256/6342bedb8c14/fcab109f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c6a/8196256/52182e39d403/fcab109f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c6a/8196256/2027c0756c85/fcab109f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c6a/8196256/718b7a02f956/fcab109f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c6a/8196256/4877a6b17dfe/fcab109f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c6a/8196256/d644af42a08a/fcab109f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c6a/8196256/5e1042d42d09/fcab109f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c6a/8196256/6342bedb8c14/fcab109f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c6a/8196256/52182e39d403/fcab109f6.jpg

相似文献

1
Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson's disease.帕金森病中脑胆碱能神经末梢完整性与主要运动特征
Brain Commun. 2021 May 22;3(2):fcab109. doi: 10.1093/braincomms/fcab109. eCollection 2021.
2
Cholinergic brain network deficits associated with vestibular sensory conflict deficits in Parkinson's disease: correlation with postural and gait deficits.帕金森病与前庭感觉冲突缺陷相关的胆碱能脑网络缺陷:与姿势和步态缺陷的相关性。
J Neural Transm (Vienna). 2022 Aug;129(8):1001-1009. doi: 10.1007/s00702-022-02523-3. Epub 2022 Jun 26.
3
Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease.帕金森病中的丘脑胆碱能神经支配和姿势感觉整合功能。
Brain. 2013 Nov;136(Pt 11):3282-9. doi: 10.1093/brain/awt247. Epub 2013 Sep 20.
4
Dynamic balance and gait impairments in Parkinson's disease: novel cholinergic patterns.帕金森病中的动态平衡和步态障碍:新型胆碱能模式
Brain Commun. 2024 Aug 26;6(5):fcae286. doi: 10.1093/braincomms/fcae286. eCollection 2024.
5
Cholinergic innervation topography in GBA-associated de novo Parkinson's disease patients.GBA 相关散发性帕金森病患者的胆碱能神经支配分布。
Brain. 2024 Mar 1;147(3):900-910. doi: 10.1093/brain/awad323.
6
Topography of Cholinergic Nerve Terminal Vulnerability and Balance Self-Efficacy in Parkinson's Disease.帕金森病胆碱能神经末梢易损性与平衡自我效能的关系。
J Integr Neurosci. 2024 Sep 24;23(9):178. doi: 10.31083/j.jin2309178.
7
Cholinergic system correlates of postural control changes in Parkinson's disease freezers.帕金森病冻结步态患者姿势控制变化的胆碱能系统相关性。
Brain. 2023 Aug 1;146(8):3243-3257. doi: 10.1093/brain/awad134.
8
Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease.帕金森病中的白质疏松、黑质纹状体神经变性与运动症状。
Brain. 2011 Aug;134(Pt 8):2358-65. doi: 10.1093/brain/awr139. Epub 2011 Jun 8.
9
Role of the globus pallidus in motor and non-motor symptoms of Parkinson's disease.苍白球在帕金森病运动和非运动症状中的作用。
Neural Regen Res. 2025 Jun 1;20(6):1628-1643. doi: 10.4103/NRR.NRR-D-23-01660. Epub 2024 Jun 3.
10
Cholinergic systems, attentional-motor integration, and cognitive control in Parkinson's disease.帕金森病中的胆碱能系统、注意-运动整合和认知控制。
Prog Brain Res. 2022;269(1):345-371. doi: 10.1016/bs.pbr.2022.01.011. Epub 2022 Feb 4.

引用本文的文献

1
A multicenter longitudinal study of cholinergic subgroups in Parkinson disease.帕金森病胆碱能亚组的多中心纵向研究。
Nat Commun. 2025 Jul 1;16(1):5655. doi: 10.1038/s41467-025-60815-0.
2
Negative emotion modulates postural tremor variability in Parkinson's disease: A multimodal EEG and motion sensor study toward behavioral interventions.消极情绪调节帕金森病患者的姿势性震颤变异性:一项针对行为干预的多模态脑电图和运动传感器研究。
IBRO Neurosci Rep. 2025 Apr 11;18:663-671. doi: 10.1016/j.ibneur.2025.04.003. eCollection 2025 Jun.
3
Digital gait biomarkers in Parkinson's disease: susceptibility/risk, progression, response to exercise, and prognosis.

本文引用的文献

1
Prevalence and Relationship of Rest Tremor and Action Tremor in Parkinson's Disease.帕金森病中静止性震颤和运动性震颤的患病率及关系。
Tremor Other Hyperkinet Mov (N Y). 2020 Dec 23;10:58. doi: 10.5334/tohm.552.
2
A Disynaptic Circuit in the Globus Pallidus Controls Locomotion Inhibition.苍白球中的一个二突触回路控制运动抑制。
Curr Biol. 2021 Feb 22;31(4):707-721.e7. doi: 10.1016/j.cub.2020.11.019. Epub 2020 Dec 10.
3
Cholinergic Denervation Patterns Across Cognitive Domains in Parkinson's Disease.帕金森病各认知领域的胆碱能神经支配模式。
帕金森病中的数字步态生物标志物:易感性/风险、疾病进展、运动反应及预后
NPJ Parkinsons Dis. 2025 Mar 21;11(1):51. doi: 10.1038/s41531-025-00897-1.
4
Role of the Central Cholinergic Nervous System in Motor and Non-Motor Symptoms of Parkinson's Disease.中枢胆碱能神经系统在帕金森病运动和非运动症状中的作用
Curr Neuropharmacol. 2025;23(10):1232-1248. doi: 10.2174/011570159X368923250313045859.
5
Galactose Impairs Motor Performance and Cerebellar Signaling in Young Male Wistar Rats.半乳糖损害雄性幼年Wistar大鼠的运动能力和小脑信号传导。
Mol Neurobiol. 2025 Jun;62(6):7542-7556. doi: 10.1007/s12035-024-04684-6. Epub 2025 Feb 6.
6
Regional cerebral cholinergic vesicular transporter correlates of visual contrast sensitivity in Parkinson's disease: Implications for visual and cognitive function.帕金森病中区域脑胆碱能囊泡转运体与视觉对比敏感度的相关性:对视觉和认知功能的影响
Parkinsonism Relat Disord. 2025 Feb;131:107229. doi: 10.1016/j.parkreldis.2024.107229. Epub 2024 Dec 9.
7
Reduced striatal M4-cholinergic signaling following dopamine loss contributes to parkinsonian and l-DOPA-induced dyskinetic behaviors.多巴胺缺失后纹状体 M4 胆碱能信号减少导致帕金森病和左旋多巴诱导的运动障碍行为。
Sci Adv. 2024 Nov 22;10(47):eadp6301. doi: 10.1126/sciadv.adp6301. Epub 2024 Nov 20.
8
Sleep-related respiratory disruptions and laterodorsal tegmental nucleus in a mouse model of Parkinson's disease.帕金森病小鼠模型中的睡眠相关呼吸紊乱与脑桥背外侧被盖核
iScience. 2024 Oct 24;27(11):111251. doi: 10.1016/j.isci.2024.111251. eCollection 2024 Nov 15.
9
Topography of Cholinergic Nerve Terminal Vulnerability and Balance Self-Efficacy in Parkinson's Disease.帕金森病胆碱能神经末梢易损性与平衡自我效能的关系。
J Integr Neurosci. 2024 Sep 24;23(9):178. doi: 10.31083/j.jin2309178.
10
Dynamic balance and gait impairments in Parkinson's disease: novel cholinergic patterns.帕金森病中的动态平衡和步态障碍:新型胆碱能模式
Brain Commun. 2024 Aug 26;6(5):fcae286. doi: 10.1093/braincomms/fcae286. eCollection 2024.
Mov Disord. 2021 Mar;36(3):642-650. doi: 10.1002/mds.28360. Epub 2020 Nov 2.
4
Comparison of effectiveness of trihexyphenidyl and levodopa on motor symptoms in Parkinson's disease.比较三己酚汀和左旋多巴对帕金森病运动症状的疗效。
J Neural Transm (Vienna). 2020 Dec;127(12):1599-1606. doi: 10.1007/s00702-020-02257-0. Epub 2020 Oct 9.
5
Modeling Vestibular Compensation: Neural Plasticity Upon Thalamic Lesion.模拟前庭代偿:丘脑损伤后的神经可塑性
Front Neurol. 2020 May 22;11:441. doi: 10.3389/fneur.2020.00441. eCollection 2020.
6
Pathophysiology of rigidity in Parkinson's disease: Another step forward.帕金森病中强直的病理生理学:又向前迈进了一步。
Clin Neurophysiol. 2020 Aug;131(8):1971-1972. doi: 10.1016/j.clinph.2020.05.013. Epub 2020 May 29.
7
The globus pallidus orchestrates abnormal network dynamics in a model of Parkinsonism.苍白球在帕金森病模型中协调异常的网络动态。
Nat Commun. 2020 Mar 26;11(1):1570. doi: 10.1038/s41467-020-15352-3.
8
Multiple head direction signals within entorhinal cortex: origin and function.内嗅皮层中的多个头部方向信号:起源与功能。
Curr Opin Neurobiol. 2020 Oct;64:32-40. doi: 10.1016/j.conb.2020.01.015. Epub 2020 Feb 20.
9
Evolving concepts on bradykinesia.关于运动徐缓的概念演变。
Brain. 2020 Mar 1;143(3):727-750. doi: 10.1093/brain/awz344.
10
Cerebral differences between dopamine-resistant and dopamine-responsive Parkinson's tremor.多巴胺抵抗型和多巴胺反应型帕金森震颤的大脑差异。
Brain. 2019 Oct 1;142(10):3144-3157. doi: 10.1093/brain/awz261.